ID APOH_MOUSE Reviewed; 345 AA. AC Q01339; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 27-MAR-2024, entry version 179. DE RecName: Full=Beta-2-glycoprotein 1; DE AltName: Full=APC inhibitor; DE AltName: Full=Activated protein C-binding protein; DE AltName: Full=Apolipoprotein H; DE Short=Apo-H; DE AltName: Full=Beta-2-glycoprotein I; DE Short=B2GPI; DE Short=Beta(2)GPI; DE Flags: Precursor; GN Name=Apoh; Synonyms=B2gp1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=1339387; DOI=10.1016/0888-7543(92)90022-k; RA Nonaka M., Matsuda Y., Shiroishi T., Moriwak K., Natsuume-Sakai S.; RT "Molecular cloning of mouse beta 2-glycoprotein I and mapping of the gene RT to chromosome 11."; RL Genomics 13:1082-1087(1992). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=CBA/J; TISSUE=Liver; RX PubMed=7514402; DOI=10.1006/bbrc.1994.1623; RA Sellar G.C., Steel D.M., Zafiropoulos A., Seery L.T., Whitehead A.S.; RT "Characterization, expression and evolution of mouse beta 2-glycoprotein I RT (apolipoprotein H)."; RL Biochem. Biophys. Res. Commun. 200:1521-1528(1994). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=BALB/cJ; TISSUE=Liver; RA Kristensen T.; RT "Structure of the human beta-2-glycoprotein I gene."; RL Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=FVB/N; TISSUE=Liver; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-117 AND ASN-162. RC STRAIN=C57BL/6J; TISSUE=Plasma; RX PubMed=16944957; DOI=10.1021/pr060186m; RA Ghesquiere B., Van Damme J., Martens L., Vandekerckhove J., Gevaert K.; RT "Proteome-wide characterization of N-glycosylation events by diagonal RT chromatography."; RL J. Proteome Res. 5:2438-2447(2006). RN [6] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-105; ASN-117; ASN-162; ASN-183 RP AND ASN-193. RC STRAIN=C57BL/6J; TISSUE=Plasma; RX PubMed=17330941; DOI=10.1021/pr0604559; RA Bernhard O.K., Kapp E.A., Simpson R.J.; RT "Enhanced analysis of the mouse plasma proteome using cysteine-containing RT tryptic glycopeptides."; RL J. Proteome Res. 6:987-995(2007). RN [7] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas, RC Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Binds to various kinds of negatively charged substances such CC as heparin, phospholipids, and dextran sulfate. May prevent activation CC of the intrinsic blood coagulation cascade by binding to phospholipids CC on the surface of damaged cells. CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- TISSUE SPECIFICITY: Expressed by the liver and secreted in plasma. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D10056; BAA00945.1; -; mRNA. DR EMBL; S70439; AAB30789.1; -; mRNA. DR EMBL; Y11356; CAA72190.1; -; mRNA. DR EMBL; BC019811; AAH19811.1; -; mRNA. DR EMBL; BC053338; AAH53338.1; -; mRNA. DR CCDS; CCDS25574.1; -. DR PIR; A43286; NBMS. DR RefSeq; NP_038503.4; NM_013475.4. DR AlphaFoldDB; Q01339; -. DR SMR; Q01339; -. DR BioGRID; 198165; 8. DR IntAct; Q01339; 1. DR STRING; 10090.ENSMUSP00000000049; -. DR GlyConnect; 652; 1 N-Linked glycan (1 site). DR GlyCosmos; Q01339; 6 sites, 2 glycans. DR GlyGen; Q01339; 6 sites, 2 N-linked glycans (1 site). DR iPTMnet; Q01339; -. DR PhosphoSitePlus; Q01339; -. DR SwissPalm; Q01339; -. DR CPTAC; non-CPTAC-3894; -. DR jPOST; Q01339; -. DR MaxQB; Q01339; -. DR PaxDb; 10090-ENSMUSP00000000049; -. DR PeptideAtlas; Q01339; -. DR ProteomicsDB; 281901; -. DR Antibodypedia; 874; 608 antibodies from 40 providers. DR DNASU; 11818; -. DR Ensembl; ENSMUST00000000049.6; ENSMUSP00000000049.6; ENSMUSG00000000049.12. DR GeneID; 11818; -. DR KEGG; mmu:11818; -. DR UCSC; uc007mbp.2; mouse. DR AGR; MGI:88058; -. DR CTD; 350; -. DR MGI; MGI:88058; Apoh. DR VEuPathDB; HostDB:ENSMUSG00000000049; -. DR eggNOG; KOG4297; Eukaryota. DR GeneTree; ENSGT00940000157228; -. DR HOGENOM; CLU_020107_2_0_1; -. DR InParanoid; Q01339; -. DR OMA; TFAVMRQ; -. DR OrthoDB; 4131542at2759; -. DR PhylomeDB; Q01339; -. DR TreeFam; TF334137; -. DR Reactome; R-MMU-114608; Platelet degranulation. DR BioGRID-ORCS; 11818; 1 hit in 80 CRISPR screens. DR ChiTaRS; Apoh; mouse. DR PRO; PR:Q01339; -. DR Proteomes; UP000000589; Chromosome 11. DR RNAct; Q01339; Protein. DR Bgee; ENSMUSG00000000049; Expressed in left lobe of liver and 63 other cell types or tissues. DR ExpressionAtlas; Q01339; baseline and differential. DR GO; GO:0009986; C:cell surface; ISO:MGI. DR GO; GO:0042627; C:chylomicron; ISO:MGI. DR GO; GO:0005615; C:extracellular space; IDA:MGI. DR GO; GO:0034364; C:high-density lipoprotein particle; ISO:MGI. DR GO; GO:0034361; C:very-low-density lipoprotein particle; ISO:MGI. DR GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW. DR GO; GO:0042802; F:identical protein binding; ISO:MGI. DR GO; GO:0008289; F:lipid binding; ISO:MGI. DR GO; GO:0060230; F:lipoprotein lipase activator activity; ISO:MGI. DR GO; GO:0005543; F:phospholipid binding; ISO:MGI. DR GO; GO:0031100; P:animal organ regeneration; ISO:MGI. DR GO; GO:0007597; P:blood coagulation, intrinsic pathway; ISO:MGI. DR GO; GO:0016525; P:negative regulation of angiogenesis; ISO:MGI. DR GO; GO:0030195; P:negative regulation of blood coagulation; ISO:MGI. DR GO; GO:0010596; P:negative regulation of endothelial cell migration; ISO:MGI. DR GO; GO:0001937; P:negative regulation of endothelial cell proliferation; ISO:MGI. DR GO; GO:0051918; P:negative regulation of fibrinolysis; ISO:MGI. DR GO; GO:0033033; P:negative regulation of myeloid cell apoptotic process; ISO:MGI. DR GO; GO:0060268; P:negative regulation of respiratory burst; ISO:MGI. DR GO; GO:0034392; P:negative regulation of smooth muscle cell apoptotic process; ISO:MGI. DR GO; GO:0031639; P:plasminogen activation; ISO:MGI. DR GO; GO:0010898; P:positive regulation of triglyceride catabolic process; ISO:MGI. DR GO; GO:0030193; P:regulation of blood coagulation; IMP:MGI. DR GO; GO:0051917; P:regulation of fibrinolysis; ISO:MGI. DR GO; GO:0006641; P:triglyceride metabolic process; ISO:MGI. DR GO; GO:0034197; P:triglyceride transport; ISO:MGI. DR CDD; cd00033; CCP; 4. DR Gene3D; 2.10.70.10; Complement Module, domain 1; 5. DR InterPro; IPR035976; Sushi/SCR/CCP_sf. DR InterPro; IPR015104; Sushi_2. DR InterPro; IPR000436; Sushi_SCR_CCP_dom. DR PANTHER; PTHR19325; COMPLEMENT COMPONENT-RELATED SUSHI DOMAIN-CONTAINING; 1. DR PANTHER; PTHR19325:SF567; LOCOMOTION-RELATED PROTEIN HIKARU GENKI; 1. DR Pfam; PF00084; Sushi; 4. DR Pfam; PF09014; Sushi_2; 1. DR SMART; SM00032; CCP; 5. DR SUPFAM; SSF57535; Complement control module/SCR domain; 5. DR PROSITE; PS50923; SUSHI; 4. DR Genevisible; Q01339; MM. PE 1: Evidence at protein level; KW Disulfide bond; Glycoprotein; Heparin-binding; Reference proteome; Repeat; KW Secreted; Signal; Sushi. FT SIGNAL 1..19 FT CHAIN 20..345 FT /note="Beta-2-glycoprotein 1" FT /id="PRO_0000002060" FT DOMAIN 21..81 FT /note="Sushi 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DOMAIN 82..139 FT /note="Sushi 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DOMAIN 140..202 FT /note="Sushi 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DOMAIN 203..262 FT /note="Sushi 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT REGION 263..345 FT /note="Sushi-like" FT CARBOHYD 33 FT /note="O-linked (GalNAc...) threonine" FT /evidence="ECO:0000250|UniProtKB:P17690" FT CARBOHYD 105 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:17330941" FT CARBOHYD 117 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:16944957, FT ECO:0000269|PubMed:17330941" FT CARBOHYD 162 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:16944957, FT ECO:0000269|PubMed:17330941" FT CARBOHYD 183 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:17330941" FT CARBOHYD 193 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:17330941" FT DISULFID 23..66 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 51..79 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 84..124 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 110..137 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 142..188 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 174..200 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 205..248 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 234..260 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 264..315 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 300..325 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 307..345 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT CONFLICT 252 FT /note="G -> R (in Ref. 2; AAB30789)" FT /evidence="ECO:0000305" SQ SEQUENCE 345 AA; 38619 MW; C83F8A6EBD51C940 CRC64; MVSPVLALFS AFLCHVAIAG RICPKPDDLP FATVVPLKTS YDPGEQIVYS CKPGYVSRGG MRRFTCPLTG MWPINTLRCV PRVCPFAGIL ENGIVRYTSF EYPKNISFAC NPGFFLNGTS SSKCTEEGKW SPDIPACARI TCPPPPVPKF ALLKDYRPSA GNNSLYQDTV VFKCLPHFAM IGNDTVMCTE QGNWTRLPEC LEVKCPFPPR PENGYVNYPA KPVLLYKDKA TFGCHETYKL DGPEEAECTK TGTWSFLPTC RESCKLPVKK ATVLYQGMRV KIQEQFKNGM MHGDKIHFYC KNKEKKCSYT VEAHCRDGTI EIPSCFKEHS SLAFWKTDAS ELTPC //